Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),” Request for Application Number (RFA) DP07-002, 19207 [E7-7245]

Download as PDF 19207 Federal Register / Vol. 72, No. 73 / Tuesday, April 17, 2007 / Notices 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project List of Ingredients Added to Tobacco in the Manufacture of Cigarette Products (OMB No. 0920–0210)—Extension— National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Comprehensive Smoking Education Act of 1984 (15 U.S.C. 1336 or Pub. L. 98–474) requires each person who manufactures, packages, or imports cigarettes to provide the Secretary of Health and Human Services (HHS) with a list of ingredients added to tobacco in the manufacture of cigarettes. This legislation also authorizes HHS to undertake research, and to report to the Congress (as deemed appropriate) discussing the health effects of these ingredients. HHS has delegated responsibility for the implementation of this Act to CDC’s Office on Smoking and Health (OSH). OSH has collected ingredient reports on cigarette products since 1986. Cigarette smoking is the leading preventable cause of premature death and disability in our Nation. Each year more than 400,000 premature deaths occur as the result of cigarette smoking related diseases. The Centers for Disease Control and Prevention (CDC), Office on Smoking and Health (OSH) has been delegated the authority for implementing major components of the Department of Health and Human Services (HHS) tobacco and health program, including collection of tobacco ingredients information. HHS’s overall goal is to reduce death and disability resulting from cigarette smoking and other forms of tobacco use through programs of information, education and research. There is no cost to the respondents other than their time to complete the survey. ESTIMATED ANNUALIZED BURDEN HOURS Cigarettes Manfacturers .......................................................... Dated: April 11, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–7238 Filed 4–16–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),’’ Request for Application Number (RFA) DP07–002 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 12 p.m.–4 p.m., June 12, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) VerDate Aug<31>2005 19:39 Apr 16, 2007 Jkt 211001 No. of responses per respondent No. of respondents Respondents 38 1 and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to RFA DP07–002, ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8).’’ FOR FURTHER INFORMATION CONTACT: Maurine Goodman, M.A., M.P.H., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, telephone 404– 639–4737. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7245 Filed 4–16–07; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Average burden per response (in hours) Total burden (in hours) 37 1406 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH)Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following committee meeting: Name: Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health. Committee Meeting Times and Dates: 8 a.m.–5 p.m., May 2, 2007. 8 a.m.–5:30 p.m., May 3, 2007. 8 a.m.–12:15 p.m., May 4, 2007. Public Comment Times and Dates: 5 p.m.–6 p.m., May 2, 2007. 7:30 p.m.–9 p.m., May 3, 2007. Place: Westin Westminster, 10600 Westminster Boulevard, Westminster, Colorado 80020, Phone 303.410.5000, Fax 303.410.5005. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 75 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program (EEOICP) Act of 2000 to advise the President on a variety of policy and technical functions E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 72, Number 73 (Tuesday, April 17, 2007)]
[Notices]
[Page 19207]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel ``Health Promotion and Disease Prevention Research 
Centers: Special Interest Project Competitive Supplements (Panel 8),'' 
Request for Application Number (RFA) DP07-002

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.
    Time and Date: 12 p.m.-4 p.m., June 12, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in response 
to RFA DP07-002, ``Health Promotion and Disease Prevention Research 
Centers: Special Interest Project Competitive Supplements (Panel 8).''

FOR FURTHER INFORMATION CONTACT: Maurine Goodman, M.A., M.P.H., 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, 
telephone 404-639-4737.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-7245 Filed 4-16-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.